Русская версия English version   
О журнале
Редакционная коллегия
Правила для авторов
Информация для читателей и авторов
Оглавление текущего номера
Архив
Контакты
Поиск

Отправить статью
 


Том 19   Выпуск 2   Год 2024
Список литературы

  1. Mehta P., Grant L.M., Reddivari A.K.R. Viral Hepatitis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK554549/ (accessed 22.11.2024).
  2. Khullar V., Firpi R.J. Hepatitis C cirrhosis: New perspectives for diagnosis and treatment. World J. Hepatol. 2015;7(14):1843–1855. doi: 10.4254/wjh.v7.i14.1843
  3. Cortesi P.A., Fornari C., Conti S., Antonazzo I.C., Ferrara P., Ahmed A., Andrei C.L., Andrei T., Artamonov A.A., Banach M. et al. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019. Lancet Public Health. 2023;8(9):e701–e716. doi: 10.1016/S2468-2667(23)00149-4
  4. Center R.J., Boo I., Phu L., McGregor J., Poumbourios P., Drummer H.E. Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine. J. Biol. Chem. 2020;295(21):7179–7192. doi: 10.1074/jbc.RA120.013015
  5. Laugel E., Hartard C., Jeulin H., Berger S., Venard V., Bronowicki J.-P., Schvoerer E. Full-length genome sequencing of RNA viruses-How the approach can enlighten us on hepatitis C and hepatitis E viruses. Rev. Med. Virol. 2021;31(4):e2197. doi: 10.1002/rmv.2197
  6. Daniel H.D., David J., Raghuraman S., Gnanamony M., Chandy G.M., Sridharan G., Abraham P. Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India. J. Clin. Lab. Anal. 2017;31(3). Article No. e22045. doi: 10.1002/jcla.22045
  7. Pascut D., Hoang M., Nguyen N.N.Q., Pratama M.Y., Tiribelli C. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers (Basel). 2021;13(10). Article No. 2485. doi: 10.3390/cancers13102485
  8. Hoofnagle J. H. Hepatitis C: the clinical spectrum of disease. Hepatology. 1997;26:15S–20S. doi: 10.1002/hep.510260703
  9. Kumar A., Rohe T.C., Elrod E.J., Khan A.G., Dearborn A.D., Kissinger R., Grakoui A., Marcotrigiano J. Regions of hepatitis C virus E2 required for membrane association. Nat. Commun. 2023;14(1). Article No. 433. doi: 10.1038/s41467-023-36183-y
  10. Yang J., Qi J.-L., Wang X.-X., Li X.-H., Jin R., Liu B.-Y., Liu H.-X., Rao H.-Y. The burden of hepatitis C virus in the world. China, India, and the United States from 1990 to 2019. Front. Public Health. 2023;11. Article No. 1041201. doi: 10.3389/fpubh.2023.1041201
  11. Roger S., Ducancelle A., Le Guillou-Guillemette H., Gaudy C., Lunel F. HCV virology and diagnosis. Clin. Res. Hepatol. Gastroenterol. 2021;45(3). Article No. 101626. doi: 10.1016/j.clinre.2021.101626
  12. Umer M., Iqbal M. Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data. World J. Gastroenterol. 2016;22(4):1684–1700. doi: 10.3748/wjg.v22.i4.1684
  13. Pan X., Kortemme T. Recent advances in de novo protein design: Principles, methods, and applications. J. Biol. Chem. 2021;296. Article No. 100558. doi: 10.1016/j.jbc.2021.100558
  14. Jakobsen J.C., Nielsen E.E., Feinberg J., Katakam K.K., Fobian K., Hauser G., Poropat G., Djurisic S., Weiss K.H., Bjelakovic M. et al. Direct-acting antivirals for chronic hepatitis C. Cochrane Database Syst. Rev. 2017. Iss. 9. Article No. CD012143. doi: 10.1002/14651858.CD012143.pub3
  15. Gonzales Zamora J.A. Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida. Diseases. 2018;6(2). Article No. 51. doi: 10.3390/diseases6020051
  16. Pierce B.G., Keck Z.-Y., Wang R., Lau P., Garagusi K., Elkholy K., Toth E.A., Urbanowicz R.A., Guest J.D., Agnihotri P. et al. Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization. J. Virol. 2020;94(22). Article No. e00704-20. doi: 10.1128/JVI.00704-20
  17. Ali R.A., Awadalla E.A., Amin Y.A., Fouad S.S., Ahmed M.A.-E.B., Hassan M.H., Abdel-Kahaar E., Abdel-Aziz R.H. The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes. Sci. Rep. 2024;14(1). Article No. 5682. doi: 10.1038/s41598-024-55950-5
  18. Sepulveda-Crespo D., Resino S., Martinez I. Hepatitis C virus vaccine design: focus on the humoral immune response. J. Biomed. Sci. 2020;27(1). Article No. 78. doi: 10.1186/s12929-020-00669-4
  19. Kucera T., Togninalli M., Meng-Papaxanthos L. Conditional generative modeling for de novo protein design with hierarchical functions. Bioinformatics. 2022;38(13):3454–3461. doi: 10.1093/bioinformatics/btac353
  20. Ovchinnikov S., Huang P. S. Structure-based protein design with deep learning. Curr. Opin. Chem. Biol. 2021;65:136–144. doi: 10.1016/j.cbpa.2021.08.004
  21. Ferruz N., Heinzinger M., Akdel M., Goncearenco A., Naef L., Dallago C. From sequence to function through structure: Deep learning for protein design. Comput. Struct. Biotechnol. J. 2023;21:238–250. doi: 10.1016/j.csbj.2022.11.014
  22. Koehl P., Levitt M. De novo protein design. I. In search of stability and specificity. J. Mol. Biol. 1999;293(5):1161–1181. doi: 10.1006/jmbi.1999.3211
  23. The UniProt Consortium, UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49(D1):D480–D489. doi: 10.1093/nar/gkaa1100
  24. Segura J., Rose Y., Bi C., Duarte J., Burley S.K., Bittrich S. RCSB Protein Data Bank: visualizing groups of experimentally determined PDB structures alongside computed structure models of proteins. Front. Bioinform. 2023;3. Article No. 1311287. doi: 10.3389/fbinf.2023.1311287
  25. Huang C.C., Meng E.C., Morris J.H., Pettersen E.F., Ferrin T.E. Enhancing UCSF Chimera through web services. Nucleic Acids Res. 2014;42. P. W478–W484. doi: 10.1093/nar/gku377
  26. Paysan-Lafosse T., Blum M., Chuguransky S., Grego T., Pinto B.L., Salazar G.A., Bileschi M.L., Bork P., Bridge A., Colwell L. et al. InterPro in 2022. Nucleic Acids Res. 2023;51:D418–D427. doi: 10.1093/nar/gkac993
  27. Lill M.A., Danielson M.L. Computer-aided drug design platform using PyMOL. J. Comput. Aided Mol. Des. 2010;25(1):13–19. doi: 10.1007/s10822-010-9395-8
  28. Varadi M., Anyango S., Deshpande M., Nair S., Natassia C., Yordanova G., Yuan D., Stroe O., G. Wood, A. Laydon et al., AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439–D444. doi: 10.1093/nar/gkab1061
  29. Haron F.N., Azazi A., Chua K.H., Lim Y.A.L., Lee P.C., Chew C.H. In silico structural modeling and quality assessment of Plasmodium knowlesi apical membrane antigen 1 using comparative protein models. Trop. Biomed. 2022;39(3):394–401. doi: 10.47665/tb.39.3.009
  30. Messaoudi A., Belguith H., Ben Hamida J. Homology modeling and virtual screening approaches to identify potent inhibitors of VEB-1 β-lactamase. Theor. Biol. Med. Model. 2013;10. Article No. 22. doi: 10.1186/1742-4682-10-22
  31. Desta I.T., Kotelnikov S., Jones G., Ghani U., Abyzov M., Kholodov Y., Standley D.M., Beglov D., Vajda S., Kozakov D. The ClusPro AbEMap web server for the prediction of antibody epitopes. Nat. Protoc. 2023;18(6):1814–1840. doi: 10.1038/s41596-023-00826-7
  32. Alekseenko A., Ignatov M., Jones G., Sabitova M., Kozakov D. Protein-Protein and Protein-Peptide Docking with ClusPro Server. Methods Mol. Biol. 2020;2165:157–174. doi: 10.1007/978-1-0716-0708-4_9
  33. Laskowski R.A., Thornton J.M. PDBsum extras: SARS-CoV-2 and AlphaFold models. Protein Sci. 2022;31(1):283–289. doi: 10.1002/pro.4238
  34. Laskowski R.A., Jabłońska J., Pravda L., Vařeková R.S., Thornton J.M. PDBsum: Structural summaries of PDB entries. Protein Sci. 2018;27(1):129–134. doi: 10.1002/pro.3289
  35. Ferruz N., Schmidt S., Höcker B. ProtGPT2 is a deep unsupervised language model for protein design. Nat. Commun. 2022;13(1). Article No. 4348. doi: 10.1038/s41467-022-32007-7
  36. Bradley P., Misura K.M., Baker D. Toward high-resolution de novo structure prediction for small proteins. Science. 2005;309:1868–1871. doi: 10.1126/science.1113801
  37. Booth J.C., Kumar U., Webster D., Monjardino J., Thomas H.C. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology. 1998;27(1):223–227. doi: 10.1002/hep.510270134
  38. Ashfaq U.A., Javed T., Rehman S., Nawaz Z., Riazuddin S. An overview of HCV molecular biology, replication and immune responses. Virol. J. 2011;8. Article No. 161. doi: 10.1186/1743-422X-8-161
  39. Martinello M., Solomon S.S., Terrault N.A., Dore G.J. Hepatitis C. Lancet. 2023;402(10407):1085–1096. doi: 10.1016/S0140-6736(23)01320-X
  40. Piselli P., Serraino D., Fusco M., Girardi E., Pirozzi A., Toffolutti F., Cimaglia C., Taborelli M.; Collaborating Study Group. Hepatitis C virus infection and risk of liver-related and non-liver-related deaths: a population-based cohort study in Naples, southern Italy. BMC Infect. Dis. 2021;21(1). Article No. 667. doi: 10.1186/s12879-021-06336-9
  41. Watson J.L., Juergens D., Bennett N.R., Trippe B.L., Yim J., Eisenach H.E., Ahern W., Borst A.J., Ragotte R.J., Milles L.F. et al. De novo design of protein structure and function with RFdiffusion. Nature. 2023;620(7976):1089–1100. doi: 10.1038/s41586-023-06415-8
  42. Kong L., Giang E., Nieusma T., Kadam R.U., Cogburn K.E., Hua Y., Dai X., Stanfield R.L., Burton D.R., Ward A.B., Wilson I.A., Law M. Hepatitis C virus E2 envelope glycoprotein core structure. Science. 2013;342(6162):1090–1094. doi: 10.1126/science.1243876
  43. Dobrica M.O., van Eerde A., Tucureanu C., Onu A., Paruch L., Caras I., Vlase E., Steen H., Haugslien S., Alonzi D. et al. Hepatitis C virus E2 envelope glycoprotein produced in Nicotiana benthamiana triggers humoral response with virus-neutralizing activity in vaccinated mice. Plant Biotechnol. J. 2021;19(10):2027–2039. doi: 10.1111/pbi.13631
  44. Zhong W., Uss A.S., Ferrari E., Lau J.Y., Hong Z. De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J. Virol. 2000;74(4):2017–2022. doi: 10.1128/JVI.74.4.2017-2022.2000
  45. He L., Tzarum N., Lin X., Shapero B., Sou C., Mann C.J., Stano A., Zhang L., Nagy K., Giang E. et al. Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines. Sci. Adv. 2020;6(16). Article No. eaaz6225. doi: 10.1126/sciadv.aaz6225
  46. Shirasago Y., Fukazawa H., Nagase S., Shimizu Y., Mizukami T., Wakita T., Suzuki T., Tani H., Kondoh M., Kuroda T. et al. A single mutation in the E2 glycoprotein of hepatitis C virus broadens the claudin specificity for its infection. Sci. Rep. 2022;12(1). Article No. 20243. doi: 10.1038/s41598-022-23824-3
  47. Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C., Olson W.C., Gardner J.P., Dragic T. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc. Natl. Acad. Sci. USA. 2004;101(39):14067–14072. doi: 10.1073/pnas.0405695101
  48. Nguyen N.N.T., Lim Y.S., Nguyen L.P., Tran S.C., Luong T.T.D., Nguyen T.T.T., Pham H.T., Mai H.N., Choi J.W., Han S.S. et al. Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation. Sci. Rep. 2018;8(1). Article No. 15486. doi: 10.1038/s41598-018-33861-6
  49. Lyu J., Imachi H., Fukunaga K., Yoshimoto T., Zhang H., Murao K. Roles of lipoprotein receptors in the entry of hepatitis C virus. World J. Hepatol. 2015;7(24):2535–2542. doi: 10.4254/wjh.v7.i24.2535
Содержание
Оригинальная статья
Noor N. Al-Hayani, Mohammed R. Mohaisen, Sara A.A. Rashid Deep Learning-Assisted Design of de novo Protein Binders Targeting Hepatitis C Virus E2 Protein. Маthematical biology and bioinformatics. 2024;19(2):402-417. doi: 10.17537/2024.19.402
(опубликована на англ. яз.)

Аннотация (англ.)
Аннотация (рус.)
Полный текст (англ., pdf)
Список литературы
Доп. материалы

 
  Copyright ИМПБ РАН © 2005-2026